A development and license agreement powered a Canadian medical tech stock Thursday. Here’s some small stocks making big moves on Thursday, June 4, 2020 (as of 4 pm EST):
Titan Medical Inc. (TSX:TMD), a Canadian medical tech stock, surged 486% to $2.11 on Thursday after announcing a development and license agreement with Medtronic plc to further the development of robotic-assisted surgical technologies.
As well, shares of Guyana Goldfields Inc. (TSX:GUY) jumped 16% to $1.70 as the junior gold miner said it has received a takeover offer from a foreign-based multinational mining company valued at C$1.85 per share in cash, which Guyana Goldfields’ Board has determined to be “superior” to the offer from Silvercorp Metals.
Intermap Technologies (TSX:IMP), meanwhile, reported an Amended Settlement Agreement with Pender Funds, in which all outstanding Vertex Notes totaling US$33.9 million shall be settled for US$1 million in cash. IMP also announced a 100% year-over-year increase in its first-quarter revenue to US$1.6 million. Intermap Technologies stock popped 122% to $0.355 following the announcement.
Finally, Aztec Minerals Corp. (TSXV:AZT) shares gained 9% to $0.36 after the junior explorer announced that its 2020 focus is on drilling the Tombstone silver-gold-zinc-lead-copper district in Arizona.
Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.
To read our full disclosure, please click on the button below:
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.
Titan Medical Inc. (TSX:TMD), a Canadian medical tech stock, surged 486% to $2.11 on Thursday after announcing a development and license agreement with Medtronic plc to further the development of robotic-assisted surgical technologies.
, on Thursday.){kind=link}